Invention Grant
- Patent Title: Bicyclic pyrazolyl amines as CDK2 inhibitors
-
Application No.: US17845142Application Date: 2022-06-21
-
Publication No.: US11981671B2Publication Date: 2024-05-14
- Inventor: Joshua Hummel , Jingwei Li , Ding-Quan Qian , Liangxing Wu
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; C07D519/00
Abstract:
The present application provides bicyclic amines of Formula (I):
or a pharmaceutically acceptable salt thereof, that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
or a pharmaceutically acceptable salt thereof, that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Public/Granted literature
- US20230002376A1 BICYCLIC PYRAZOLYL AMINES AS CDK2 INHIBITORS Public/Granted day:2023-01-05
Information query
